Loading clinical trials...
Loading clinical trials...
A Telehealth Intervention to Increase Screening and Treatment for Alcohol Use Disorder
Participants with alcohol use disorder will be randomly assigned to either the Ria Treatment Platform or a waitlist control. The Ria Treatment Platform is a telehealth approach that incorporates medical assessment, medications for alcohol use disorder, individual and group coaching, educational video modules, and a Bluetooth-enabled breathalyzer. Patients are followed for three months during which data are collected, including measures of alcohol consumption and its consequences.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Stanford University
Stanford, California, United States
Start Date
January 31, 2024
Primary Completion Date
March 1, 2026
Completion Date
September 1, 2026
Last Updated
February 17, 2026
135
ESTIMATED participants
Ria Treatment Platform
COMBINATION_PRODUCT
Lead Sponsor
Ria Health
Collaborators
NCT06676059
NCT05855668
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07071779